Skip to main content

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.

About The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  203.47
-1.32 (-0.65%)
AAPL  262.50
-1.85 (-0.70%)
AMD  200.93
+0.81 (0.40%)
BAC  52.41
-0.95 (-1.78%)
GOOG  301.61
-2.33 (-0.77%)
META  639.80
-3.42 (-0.53%)
MSFT  399.30
-0.30 (-0.08%)
NVDA  186.18
-1.80 (-0.96%)
ORCL  157.39
+1.22 (0.78%)
TSLA  405.04
-6.28 (-1.53%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.